Results 31 to 40 of about 60,441 (347)

Effect of police action on low-barrier substance use disorder service utilization

Harm Reduction Journal, 2022
Background Police action can increase risky substance use patterns by people who use drugs (PWUD), but it is not known how increased police presence affects utilization of low-barrier substance use disorder bridge clinics.
Karrin Weisenthal, Simeon D. Kimmel, Jessica Kehoe, Marc R. Larochelle, Alexander Y. Walley, Jessica L. Taylor   +5 more
doaj   +1 more source

Evaluating the optimal duration of medication treatment for opioid use disorder [PDF]

Addiction, EarlyView.
Abstract Background and aims Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how the risk of all‐cause mortality changes with the duration of MOUD, controlling for patient characteristics that ...
Corey J. Hayes, Rebecca A. Raciborski, M Acharya, Nahiyan Bin Noor, Edward V. Nunes, T. John Winhusen   +5 more
openalex   +2 more sources

Stigma as a fundamental hindrance to the United States opioid overdose crisis response. [PDF]

, 2019
Alexander Tsai and co-authors discuss the role of stigma in responses to the US opioid ...
Barnett, Michael L, Beletsky, Leo, Keyes, Katherine M, Kiang, Mathew V, McGinty, Emma E, Smith, Laramie R, Strathdee, Steffanie A, Tsai, Alexander C, Venkataramani, Atheendar S, Wakeman, Sarah E   +9 more
core   +2 more sources

Contemporary management of pain in cirrhosis: Toward precision therapy for pain

Hepatology, EarlyView., 2022
Abstract Chronic pain is highly prevalent in patients with cirrhosis and is associated with poor health‐related quality of life and poor functional status. However, there is limited guidance on appropriate pain management in this population, and pharmacologic treatment can be harmful, leading to adverse outcomes, such as gastrointestinal bleeding ...
Alexis Holman, Neehar Parikh, Dan J. Clauw, David A. Williams, Elliot B. Tapper   +4 more
wiley   +1 more source

Review of medication-assisted treatment for opioid use disorder

Journal of Osteopathic Medicine, 2022
Abstract Context The American opioid epidemic has necessitated the search for safe and effective means of treatment for opioid use disorder (OUD). Medication-assisted treatment (MAT) encompasses select medications that are proven effective treatments for OUD.
Nessreen, Ghanem, Devin, Dromgoole, Ahmad, Hussein, Richard T, Jermyn   +3 more
openaire   +2 more sources

An evaluation of the association between specific post‐overdose care services in emergency departments and subsequent treatment engagement

Journal of the American College of Emergency Physicians Open, 2023
Objective The objective of this study was to estimate the association between receipt of specific post‐overdose care services in the emergency department (ED) and subsequent engagement in treatment for opioid use disorder (OUD) after discharge.
Laura C. Chambers, Benjamin D. Hallowell, Elizabeth A. Samuels, Mackenzie Daly, Janette Baird, Francesca L. Beaudoin   +5 more
doaj   +1 more source

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data

Ibrain, EarlyView., 2023
This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju, Samyuktha Villavan, Saranya Ravi, Roja Murugesan, Panneerselvam Theivendren, Vennila Jaganathan, Redlin Jani Rajan, Krupanidhi Karunanithi   +7 more
wiley   +1 more source

Qualitative exploration of the early experiences of opioid use disorder patients from private clinics after Russia’s invasion of Ukraine in five major cities in Ukraine

Frontiers in Public Health, 2023
IntroductionFollowing the full-scale invasion of Ukraine by the Russian Federation on 24 February 2022, over 6,000 patients were at risk of potential disruptions in treatment with medications for opioid use disorder (MOUD) in Ukraine.
Alyona Mazhnaya, Anna Meteliuk, Iryna Pykalo, Frederick L. Altice, Frederick L. Altice   +4 more
doaj   +1 more source

Influences of the criminal justice system on use of medications for opioid use disorder: a qualitative study. [PDF]

BMC Glob Public Health
Taylor E, Gray C, Stimmel M, Binswanger IA, Morse E, Timko C, Harris AHS, Smelson D, Finlay AK.   +8 more
europepmc   +3 more sources